CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Cash Provided by (Used in) Financing Activities, Discontinued Operations
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Cash Provided by (Used in) Financing Activities, Discontinued Operations of $0 for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations · last filed 2012-05-04
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash provided by (used in) financing activities, discontinued operations for the quarter ending 2012-03-31 was $0.00, a 100.00% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash provided by (used in) financing activities, discontinued operations for the quarter ending 2011-03-26 was $213.00K, a 1421.43% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash provided by (used in) financing activities, discontinued operations for the quarter ending 2010-03-27 was $14.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash provided by (used in) financing activities, discontinued operations for fiscal 2011 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash provided by (used in) financing activities, discontinued operations for fiscal 2010 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash provided by (used in) financing activities, discontinued operations for fiscal 2009 was $0.00, a 100.00% decline from fiscal 2008.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash provided by (used in) financing activities, discontinued operations for fiscal 2008 was $349.00K.
| Period end | Cash Provided by (Used in) Financing Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 12 month | Cash Provided by (Used in) Financing Activities, Discontinued Operations 12 month as first filed |
|---|---|---|---|
| 2012-03-31 | $0.00 10-Q · filed 2012-05-04 | ||
| 2011-12-31 | $0.00 10-K · filed 2012-02-27 | ||
| 2011-03-26 | $213.00K 10-Q · filed 2012-05-04 | ||
| 2010-12-25 | $0.00 10-K · filed 2012-02-27 | $63.00K 10-K · filed 2011-02-23 | |
| 2010-03-27 | $14.00K 10-Q · filed 2011-05-04 | ||
| 2009-12-26 | $0.00 10-K · filed 2012-02-27 | $41.00K 10-K · filed 2011-02-23 | |
| 2008-12-27 | $349.00K 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |